Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 50 points on Tuesday.
Myriad Genetics Q3 Earnings Fall Short Of Expectations, Lowers Annual Outlook
Myriad Genetics Inc (NASDAQ:MYGN) has acquired Gateway Genomics LLC, a personal genomics company and developer of consumer genetic tests, including…
Dow Drops Over 200 Points; Crude Oil Rises Sharply
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Tuesday.
Analyst Initiates Coverage On This Genetic Testing Stock With Ongoing Transformation
Stephens initiated coverage on Myriad Genetics Inc (NASDAQ:MYGN) with an Equal-Weight rating and a price target of $22. The analyst writes that…
SVB Leerink Maintains Market Perform on Myriad Genetics, Raises Price Target to $30
SVB Leerink analyst Puneet Souda maintains Myriad Genetics (NASDAQ:MYGN) with a Market Perform and raises the price target from $26 to $30.
Earnings Scheduled For August 4, 2022
Companies Reporting Before The Bell
• Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
